Impact of symptom clusters on quality of life outcomes in patients from japan with advanced nonsmall cell lung cancers

被引:28
作者
Hamada, Tamami [1 ,9 ]
Komatsu, Hiroko [2 ]
Rosenzweig, Margaret Quinn [3 ,4 ]
Chohnabayashi, Naohiko [5 ]
Nishimura, Naoki [5 ]
Oizumi, Satoshi [6 ]
Ren, Dianxu [7 ,8 ]
机构
[1] Asahikawa Med Univ, Dept Nursing, Asahikawa, Hokkaido, Japan
[2] Keio Univ, Fac Nursing & Med Care, Tokyo, Japan
[3] Univ Pittsburgh, Sch Nursing, Dept Acute Care, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Sch Nursing, Dept Tertiary Care, Pittsburgh, PA 15260 USA
[5] St Lukes Int Hosp, Div Pulm Med, Thorac Ctr, Tokyo, Japan
[6] Hokkaido Univ, Sch Med, Dept Med, Sapporo, Hokkaido, Japan
[7] Univ Pittsburgh, Dept Hlth, Sch Nursing, Pittsburgh, PA 15260 USA
[8] Univ Pittsburgh, Sch Nursing, Dept Community Syst, Pittsburgh, PA 15260 USA
[9] 2-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan
关键词
Advanced nonsmall cell lung cancer; cross-sectional; factor analysis; impairment of everyday life; quality of life; symptom clusters;
D O I
10.4103/2347-5625.196489
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Obich.thve: Identify symptom clusters based on symptoms experienced by patients with advanced nonsmall cell lung cancers (NSCLCs), and examine the relationship between the symptom clusters and impairment in everyday life and quality of life (Q0L). Methods: Using the M.D. Anderson Symptom Inventory, 9 symptom items and the QOL Questionnaire (QLQ-C-30) evaluation apparatus from the European Organization for Research and Treatment of Cancer, we evaluated symptom severity, interference in daily life, and QOL. Factor analysis and multiple regression analysis techniques were used. Results:Sixty patients with advanced NSCLCs seen in pulmonary medicine departments were included in the study. The average age of patients was 64.33 (standard deviation = 11.40). Thirty-six were male and 24 were female. Three symptom clusters were identified as fatigue/anorexia cluster (dry mouth, altered the sense of taste, drowsiness, fatigue/tiredness, and lack of appetite), pain cluster (anxiety, sadness, and pain), numbness cluster (numbness, leg weakness, and distress). The pain cluster had the strongest influence (adjusted R' = 0.355) on daily life (emotions) while the numbness cluster most strongly affected walking. The fatigue/anorexia cluster explained 22.7% of role function variance. This symptom clustering may be unique among patients with advanced NSCLCs. Conclusions: Each of these clusters affected QOL and everyday life with varying degrees of influence. In clinical screening assessments, focusing on symptom clusters could provide tailored management strategies for patients with advanced NSCLCs. These care strategies may improve outcomes specifically for advanced NSCLCs patients.
引用
收藏
页码:370 / 381
页数:12
相关论文
共 49 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   AN EMPIRICAL-TEST OF THE UTILITY OF THE OBSERVATIONS-TO-VARIABLES RATIO IN FACTOR AND COMPONENTS-ANALYSIS [J].
ARRINDELL, WA ;
VANDERENDE, J .
APPLIED PSYCHOLOGICAL MEASUREMENT, 1985, 9 (02) :165-178
[3]   Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: A meta-analysis [J].
Baggstrom, Maria Q. ;
Stinchcombe, Thomas E. ;
Fried, Daniel B. ;
Poole, Charles ;
Hensing, Thomas A. ;
Socinski, Mark A. .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (09) :845-853
[4]   The elusive concept of the symptom cluster [J].
Barsevick, Andrea M. .
ONCOLOGY NURSING FORUM, 2007, 34 (05) :971-980
[5]   A Symptom Cluster and Sentinel Symptom Experienced by Women With Lung Cancer [J].
Brown, Jean K. ;
Cooley, Mary E. ;
Chernecky, Cynthia ;
Sarna, Linda .
ONCOLOGY NURSING FORUM, 2011, 38 (06) :E425-E435
[6]  
Chen E, 2011, EXPERT REV PHARM OUT, V11, P433, DOI [10.1586/ERP.11.56, 10.1586/erp.11.56]
[7]  
Cleeland CS, 2000, CANCER-AM CANCER SOC, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO
[8]  
2-V
[9]  
Dodd M J, 2001, Oncol Nurs Forum, V28, P465
[10]  
Fayers P., 2001, EORTC QLQ C30 SCORIN, V3